FDA Head Makary Commits To Releasing ‘Robust’ Abortion Pill Review As Soon As It Is Completed

Go to Article

FDA Commissioner Marty Makary

The FDA’s study, Makary announced, is even ‘bigger’ and ‘more robust’ than previous mifepristone examinations.



Comment on this Article Via Your Disqus Account